Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Its low valuation, with P/E ratio at 7.79 and 11.3 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • The tendency within the weekly time frame is positive above the technical support level at 104.47 USD
Weaknesses
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Sector Other Biotechnology & Medical Research
1st jan.Capitalisation (M$)Investor Rating
MODERNA, INC.53.03%64 032
LONZA GROUP AG-1.16%45 285
IQVIA HOLDINGS INC.20.31%41 063
CELLTRION, INC.-14.21%37 856
SEAGEN INC.-16.92%27 131
INCYTE CORPORATION-4.35%18 291
HANGZHOU TIGERMED CONSULTIN..-17.02%17 971
PHARMARON BEIJING CO., LTD.21.68%17 460
ALNYLAM PHARMACEUTICALS, IN..6.86%16 310
BIO-TECHNE CORPORATION31.81%16 108
CHARLES RIVER LABORATORIES ..28.22%16 086
PPD, INC.35.21%16 050
NOVAVAX, INC.103.88%14 846
QIAGEN N.V.-0.19%12 007
ICON PUBLIC LIMITED COMPANY5.24%10 832
PRA HEALTH SCIENCES, INC.28.95%10 443
More Results
Financials (USD)
Sales 2021 17 046 M - -
Net income 2021 9 072 M - -
Net cash 2021 11 099 M - -
P/E ratio 2021 7,79x
Yield 2021 -
Capitalization 68 414 M 68 414 M -
EV / Sales 2021 3,36x
EV / Sales 2022 3,60x
Nbr of Employees 1 300
Free-Float 89,0%
Upcoming event on MODERNA, INC.
Surperformance Ratings©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes